Literature DB >> 21084291

The sphingosine 1-phosphate transporter, SPNS2, functions as a transporter of the phosphorylated form of the immunomodulating agent FTY720.

Yu Hisano1, Naoki Kobayashi, Atsuo Kawahara, Akihito Yamaguchi, Tsuyoshi Nishi.   

Abstract

FTY720 is a novel immunomodulating drug that can be phosphorylated inside cells; its phosphorylated form, FTY720-P, binds to a sphingosine 1-phosphate (S1P) receptor, S1P(1), and inhibits lymphocyte egress into the circulating blood. Although the importance of its pharmacological action has been well recognized, little is known about how FTY720-P is released from cells after its phosphorylation inside cells. Previously, we showed that zebrafish Spns2 can act as an S1P exporter from cells and is essential for zebrafish heart formation. Here, we demonstrate that human SPNS2 can transport several S1P analogues, including FTY720-P. Moreover, FTY720-P is transported by SPNS2 through the same pathway as S1P. This is the first identification of an FTY720-P transporter in cells; this finding is important for understanding FTY720 metabolism.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21084291      PMCID: PMC3023470          DOI: 10.1074/jbc.M110.171116

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists.

Authors:  Suzanne Mandala; Richard Hajdu; James Bergstrom; Elizabeth Quackenbush; Jenny Xie; James Milligan; Rosemary Thornton; Gan-Ju Shei; Deborah Card; CarolAnn Keohane; Mark Rosenbach; Jeffrey Hale; Christopher L Lynch; Kathleen Rupprecht; William Parsons; Hugh Rosen
Journal:  Science       Date:  2002-03-28       Impact factor: 47.728

2.  The immune modulator FTY720 targets sphingosine 1-phosphate receptors.

Authors:  Volker Brinkmann; Michael D Davis; Christopher E Heise; Rainer Albert; Sylvain Cottens; Robert Hof; Christian Bruns; Eva Prieschl; Thomas Baumruker; Peter Hiestand; Carolyn A Foster; Markus Zollinger; Kevin R Lynch
Journal:  J Biol Chem       Date:  2002-04-19       Impact factor: 5.157

3.  Simultaneous quantitative analysis of sphingoid base 1-phosphates in biological samples by o-phthalaldehyde precolumn derivatization after dephosphorylation with alkaline phosphatase.

Authors:  Jung-Kee Min; Hwan-Soo Yoo; Eun-Young Lee; Woo-Jin Lee; Yong-Moon Lee
Journal:  Anal Biochem       Date:  2002-04-15       Impact factor: 3.365

4.  Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform.

Authors:  H Liu; M Sugiura; V E Nava; L C Edsall; K Kono; S Poulton; S Milstien; T Kohama; S Spiegel
Journal:  J Biol Chem       Date:  2000-06-30       Impact factor: 5.157

5.  A novel method to quantify sphingosine 1-phosphate by immobilized metal affinity chromatography (IMAC).

Authors:  Yong-Moon Lee; Krishnan Venkataraman; Sun-Il Hwang; David K Han; Timothy Hla
Journal:  Prostaglandins Other Lipid Mediat       Date:  2007-08-06       Impact factor: 3.072

6.  The sphingolipid transporter spns2 functions in migration of zebrafish myocardial precursors.

Authors:  Atsuo Kawahara; Tsuyoshi Nishi; Yu Hisano; Hajime Fukui; Akihito Yamaguchi; Naoki Mochizuki
Journal:  Science       Date:  2008-12-11       Impact factor: 47.728

7.  Characterization of the ATP-dependent sphingosine 1-phosphate transporter in rat erythrocytes.

Authors:  Naoki Kobayashi; Nobuyoshi Kobayashi; Akihito Yamaguchi; Tsuyoshi Nishi
Journal:  J Biol Chem       Date:  2009-06-15       Impact factor: 5.157

8.  Involvement of the ABC-transporter ABCC1 and the sphingosine 1-phosphate receptor subtype S1P(3) in the cytoprotection of human fibroblasts by the glucocorticoid dexamethasone.

Authors:  Barbara Nieuwenhuis; Anja Lüth; Jerold Chun; Andrea Huwiler; Josef Pfeilschifter; Monika Schäfer-Korting; Burkhard Kleuser
Journal:  J Mol Med (Berl)       Date:  2009-04-17       Impact factor: 4.599

9.  FTY720 inhibits ceramide synthases and up-regulates dihydrosphingosine 1-phosphate formation in human lung endothelial cells.

Authors:  Evgeny V Berdyshev; Irina Gorshkova; Anastasia Skobeleva; Robert Bittman; Xuequan Lu; Steven M Dudek; Tamara Mirzapoiazova; Joe G N Garcia; Viswanathan Natarajan
Journal:  J Biol Chem       Date:  2009-01-01       Impact factor: 5.157

Review 10.  Production and release of sphingosine 1-phosphate and the phosphorylated form of the immunomodulator FTY720.

Authors:  Akio Kihara; Yasuyuki Igarashi
Journal:  Biochim Biophys Acta       Date:  2008-06-13
View more
  68 in total

1.  Lmo2 (LIM-Domain-Only 2) Modulates Sphk1 (Sphingosine Kinase) and Promotes Endothelial Cell Migration.

Authors:  Gianfranco Matrone; Shu Meng; Qilin Gu; Jie Lv; Longhou Fang; Kaifu Chen; John P Cooke
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-08-03       Impact factor: 8.311

2.  Non-phosphorylated FTY720 induces apoptosis of human microglia by activating SREBP2.

Authors:  Takashi Yoshino; Hiroko Tabunoki; Shigeo Sugiyama; Keitaro Ishii; Seung U Kim; Jun-Ichi Satoh
Journal:  Cell Mol Neurobiol       Date:  2011-04-26       Impact factor: 5.046

Review 3.  Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.

Authors:  Victoria A Blaho; Timothy Hla
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

Review 4.  Shaping the landscape: metabolic regulation of S1P gradients.

Authors:  Ana Olivera; Maria Laura Allende; Richard L Proia
Journal:  Biochim Biophys Acta       Date:  2012-06-23

5.  Maternal and Zygotic Sphingosine Kinase 2 Are Indispensable for Cardiac Development in Zebrafish.

Authors:  Yu Hisano; Asuka Inoue; Michiyo Okudaira; Kiyohito Taimatsu; Hirotaka Matsumoto; Hirohito Kotani; Rie Ohga; Junken Aoki; Atsuo Kawahara
Journal:  J Biol Chem       Date:  2015-04-23       Impact factor: 5.157

6.  High-Resolution Expression Profiling of Peripheral Blood CD8+ Cells in Patients with Multiple Sclerosis Displays Fingolimod-Induced Immune Cell Redistribution.

Authors:  Luisa Roch; Michael Hecker; Jörg Friess; Ines Charlotte Angerer; Dirk Koczan; Brit Fitzner; Ina Schröder; Kristin Flechtner; Hans-Jürgen Thiesen; Stefanie Meister; Alexander Winkelmann; Uwe Klaus Zettl
Journal:  Mol Neurobiol       Date:  2016-09-08       Impact factor: 5.590

7.  Distinct generation, pharmacology, and distribution of sphingosine 1-phosphate and dihydrosphingosine 1-phosphate in human neural progenitor cells.

Authors:  Phillip Callihan; Nicholas C Zitomer; Michael V Stoeling; Perry C Kennedy; Kevin R Lynch; Ronald T Riley; Shelley B Hooks
Journal:  Neuropharmacology       Date:  2011-10-15       Impact factor: 5.250

8.  Iron excess upregulates SPNS2 mRNA levels but reduces sphingosine-1-phosphate export in human osteoblastic MG-63 cells.

Authors:  L Peltier; C Bendavid; T Cavey; M-L Island; M Doyard; P Leroyer; C Allain; M De Tayrac; M Ropert; O Loréal; P Guggenbuhl
Journal:  Osteoporos Int       Date:  2018-05-03       Impact factor: 4.507

Review 9.  Sphingosine-1-phosphate in chronic intestinal inflammation and cancer.

Authors:  Masayuki Nagahashi; Nitai C Hait; Michael Maceyka; Dorit Avni; Kazuaki Takabe; Sheldon Milstien; Sarah Spiegel
Journal:  Adv Biol Regul       Date:  2013-10-16

10.  Fingolimod Suppresses the Proinflammatory Status of Interferon-γ-Activated Cultured Rat Astrocytes.

Authors:  Saša Trkov Bobnar; Matjaž Stenovec; Katarina Miš; Sergej Pirkmajer; Robert Zorec
Journal:  Mol Neurobiol       Date:  2019-01-30       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.